DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Nihonbashi Life Science HUB

2018 年 10 月 25 日 9:00 上午 - 2018 年 10 月 26 日 6:00 下午

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

[Session 7] Abstract Session 2

Session Chair(s)

Yasunari  Kanda, PhD

Yasunari Kanda, PhD

Head of Division of Pharmacology

National Institute of Health Sciences, Japan

Kaori  Shinagawa, MD, PhD

Kaori Shinagawa, MD, PhD

Senior Scientist for Clinical Medicine, Office of New Drug II

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Speaker(s)

Takako  Morooka

A Case of Spontaneous Smoking Echo in a Patient with Bladder and Pancreatic Cancer - Detection of Prothrombotic Status with Echocardiography

Takako Morooka

Nagoya University Hospital, Japan

Department of Medical Technique

Jeff  Heilbraun, MS

Blood Pressure Monitoring in Clinical Trials - from Efficacy to Safety Endpoints - Design and Technology Considerations

Jeff Heilbraun, MS

Clario, United States

Vice President, Medical and Scientific Affairs, Cardiology

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。